Trial NCT02943473

View at ClinicalTrials.gov 
Org. Study IDs: GCO 16-1867

Last trial update was posted on 2020-12-16

MeSH Interventions

Ibrutinib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell Smoldering Multiple Myeloma

Other Conditions

High Risk Smoldering Multiple Myeloma

Stopping Reasons

Poor accrual and risk/benefit ratio.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID